PAMS
ABMD

Pictet Asset Management (Switzerland)’s Abiomed Inc ABMD Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-22,960
Closed -$5.64M – 2028
2022
Q3 		$5.64M Buy
22,960
+180
+0.8% +$48.6K 0.01% 706
2022
Q2 		$5.64M Buy
22,780
+60
+0.3% +$16.2K 0.01% 733
2022
Q1 		$7.53M Buy
22,720
+700
+3% +$215K 0.01% 718
2021
Q4 		$7.91M Sell
22,020
-490
-2% -$166K 0.01% 734
2021
Q3 		$7.33M Buy
+22,510
New +$7.63M 0.01% 762

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s ABMD Position: Q4 2022 in Review

Pictet Asset Management (Switzerland) sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 22,960 shares — an estimated $5.64M sold.

Pictet Asset Management (Switzerland) first reported a position in ABMD in Q3 2021 and held it in 5 quarters. The position peaked at $7.91M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Pictet Asset Management (Switzerland) reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 22,960 Abiomed Inc shares in Q4 2022, an estimated $5.64M.
  • Pictet Asset Management (Switzerland) first reported a position in Abiomed Inc in Q3 2021 and held it in 5 quarters.
  • Pictet Asset Management (Switzerland)'s Abiomed Inc position peaked at $7.91M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q4 2022, filed 13 Feb 2023.